|
|
Article: Genetic Engineering & Biotechnology News Reports on Growing Use of Cell-Based Assays.
- Article from:
- PR Newswire
- Article date:
- April 16, 2008
|
Copyright informationCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW ROCHELLE, N.Y., April 16 /PRNewswire/ -- Biotech and pharma companies are increasingly relying on cell-based assays in early drug discovery work, reports Genetic Engineering & Biotechnology News (GEN). The technique can provide a quick and lower cost means of testing drug candidates for toxic effects, according to an article in the April 15 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2437).
"Better screening technologies, noninvasive monitoring, and more automation are driving the trend toward adoption of this technology," notes John Sterling, Editor-in-Chief of GEN. "Some estimates project that the market for cell-based assays will more than ...
Related newspaper, magazine, and journal articles:
|
|
Article: Video: GEN Video Hits Home with Web Audience.
PR Newswire;
October 2, 2007 ;
315 words
......PRNewswire/ -- Genetic Engineering and Biotechnology News' (GEN) first online video program...videos. Genetic Engineering & Biotechnology News is published 21 times a year in print...Boyce of Genetic Engineering and Biotechnology News, +1-914-740-2100, or cell, +1-516-426-...
|
|